Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Translational Andrology and Urology
|
December 10, 2025
Magnetic resonance elastography for prostate cancer: advancing diagnostic accuracy, tumor characterization, and clinical applications
Santosh Chapain, Dhananjay Kumar Yadav, Zheng Ren, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 5, 2022
Improvement of synaptic plasticity by nanoparticles and the related mechanisms: Applications and prospects
Aijie Chen, Yiyuan Kang, Jia Liu, et al.
Anti-Cancer Drugs
|
February 2, 2023
First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews
Rongrong Wu, Shinan Liu, Guoli Lv, et al.
Current Issues in Molecular Biology
|
July 26, 2024
Genome-Wide Identification and Expression Analysis of <i>BrBASS</i> Genes in <i>Brassica rapa</i> Reveals Their Potential Roles in Abiotic Stress Tolerance
Zhaojing Ji, Ruolan Wang, Meiqi Zhang, et al.
Viruses
|
March 28, 2024
Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies
Mark Underwood, Rimgaile Urbaityte, Ruolan Wang, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2021
Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study
Mark Underwood, Joe Horton, Keith Nangle, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2023
Correction for Underwood et al., "Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study"
Mark Underwood, Joe Horton, Keith Nangle, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
January 16, 2026
Pretreatment MRI radiomics for predicting pathological Miller-Payne grading in breast cancer following neoadjuvant chemotherapy
Chengliu Bi, Ao Chen, Fengming Ran, et al.
ACS Nano
|
September 19, 2022
How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects
Junrong Wu, Zhenjun Zhu, Wenjing Liu, et al.
Radiation Oncology (London, England)
|
May 16, 2026
Berberine alleviates radiation-induced intestinal injury by inhibiting cellular senescence
Xiaofeng Niu, Zheng Ren, Lijuan Deng, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Translational Andrology and Urology
|
December 10, 2025
Magnetic resonance elastography for prostate cancer: advancing diagnostic accuracy, tumor characterization, and clinical applications
Santosh Chapain, Dhananjay Kumar Yadav, Zheng Ren, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 5, 2022
Improvement of synaptic plasticity by nanoparticles and the related mechanisms: Applications and prospects
Aijie Chen, Yiyuan Kang, Jia Liu, et al.
Anti-Cancer Drugs
|
February 2, 2023
First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews
Rongrong Wu, Shinan Liu, Guoli Lv, et al.
Current Issues in Molecular Biology
|
July 26, 2024
Genome-Wide Identification and Expression Analysis of <i>BrBASS</i> Genes in <i>Brassica rapa</i> Reveals Their Potential Roles in Abiotic Stress Tolerance
Zhaojing Ji, Ruolan Wang, Meiqi Zhang, et al.
Viruses
|
March 28, 2024
Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies
Mark Underwood, Rimgaile Urbaityte, Ruolan Wang, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2021
Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study
Mark Underwood, Joe Horton, Keith Nangle, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2023
Correction for Underwood et al., "Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study"
Mark Underwood, Joe Horton, Keith Nangle, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
January 16, 2026
Pretreatment MRI radiomics for predicting pathological Miller-Payne grading in breast cancer following neoadjuvant chemotherapy
Chengliu Bi, Ao Chen, Fengming Ran, et al.
ACS Nano
|
September 19, 2022
How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects
Junrong Wu, Zhenjun Zhu, Wenjing Liu, et al.
Radiation Oncology (London, England)
|
May 16, 2026
Berberine alleviates radiation-induced intestinal injury by inhibiting cellular senescence
Xiaofeng Niu, Zheng Ren, Lijuan Deng, et al.
Page
of 7